Interferon-α and transforming growth factor-β1 regulate corticotropin-releasing factor release from the amygdala: Comparison with the hypothalamic response

Neurochemistry International

Volumn 30, Issue 4-5, 1997, Pages 455-463

  Raber, Jacob ^a,b   Koob, George F ^a   Bloom, Floyd E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA INTERFERON; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HORMONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; AMINOQUINOLINES; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; HUMANS; HYPOTHALAMUS; INTERFERON-ALPHA; INTERLEUKIN-2; MALE; METHYLENE BLUE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0030991125     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00082-4     Document Type: Article

References (85)

1. Adolphs, R., Tranel, D., Damasio, H. and Damasio, A. (1994) Impaired recognition of emotion in facial expression following bilateral damage to the human amygdala. Nature 372, 669-672.
2. Akiyama, H., Ikeda, K., Katoh, M., McGeer, E. G. and McGeer, P. L. (1994) Expression of MRP14, 27E10, interferon-α and leucocyte common antigen by reactive microglia in postmortem human brain tissue. J. Neuroimmunol. 50, 195-201.
3. Antoni, F. A. (1986) Hypothalamic control of adrenocorticotrophin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7, 351-378.
4. Balkwill, F. R. (1989) Peptide regulatory factors: interferons. The Lancet i, 1060-1063. Bassett, J. and Foote, S. L. (1992) Distribution of corticotrophin-releasing factor like immunoreactivity in squirrel monkey (Saimiri sciureus) amygdala. J. comp. Neurol. 323, 91-102.
5. Bateman, A., Singh, A., Kral, T. and Salomon, S. (1989) The immune-hypothalamic-pituitary-adrenal axis. Endocr. Rev. 10, 92-112.
6. Beaulieu, S., Pelletier, G., Vaudry, H. and Barden, N. (1989) Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence. Neuroendocrinology 49, 255-261.
7. Brandt, E. R., Mackay, I. R., Hertzog, P. J., Cheetham, B. F., Sherrit, M. and Bernard, C. C. (1993) The demonstration of intermittent interferonaemia in patients with multiple sclerosis prompted a molecular analysis of brain. J. Neuroimmunol. 44, 1-5.
8. Bredt, D. S. and Snyder, S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natn. Acad. Sci. USA. 86, 9030-9033.
9. Calogero, A., Bernardini, R., Margloris, A. N., Bagdy, A. N., Galucci, W. T., Munson, P. J., Tamarkin, L., Tomai, T. P., Bray, L., Gold, P. W. and Chrousos, P. (1989) Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10, 189-200.
10. 3H-phosphoinositides mediated by muscarinic receptors in the developing chick retina: inhibition of carbachol-induced response by glutamate receptors. J. Neurochem. 64, 1064-1070.
11. Cassell, M. D. and Gray, T. S. (1989) Morphology of peptide-immunereactive neurons in the rat central nucleus of the amygdala. J. Comp. Neurol. 281, 320-333.
12. Chappell, P. B., Smith, M. A., Kilts, C. D., Bisecette, G., Ritchie, J., Anderson, C. and Nemeroff, C. B. (1986) Alterations in corticotrophin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6, 2908-2914.
13. Chrousos, G. P. and Gold, P. W. (1992) The concepts of stress and stress system disorders: overview of physical and behavioural homeostasis. J. Am. Med. Assoc. 267, 1244-1252.
14. Cintra, A., Fuxe, K., Harfstrand, A., Agnati, L. F., Tinner, B., Wikstrom, A.-C., Vale, W. and Gustafsson, J.-A. (1987) Evidence for the presence of glucocorticoid receptor immunoreactivity in corticotropin-releasing factor and in growth hormone releasing factor immunoreactive neurones of the rat di- and telencephalon. Neurosci. Lett. 76, 269-274.
15. Cintra, A., Fuxe, K., Harfstrand, A., Agnati, L. F., Tinner, B., Wikstrom, A.-C., Vale, W. and Gustafsson, J.-A. (1991) Central peptidergic neurons as targets of glucocorticoid action: evidence for the presence of glucocorticoid immunoreactivity in various types of classes of peptidergic neurons. J. Steroid Biochem. mol. Biol. 40, 93-103.
16. Cummings, S., Elde, R., Ells, J. and Lindall, A. (1983) Corticotrophin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 3, 1355-1368.
17. 1) expression and regulation in rat cortical astrocytes. J. Neuroimmunol. 36, 157-169.
18. Dunn, J. D. and Whitener, J. (1986) Plasma corticosterone responses to electrical stimulation of the amygdaloid comples: cytoarchitectural specificity. Neuroendocrinol. 42, 211-217.
19. Elkabir, D. R., Wyatt, M. E., Velucci, S. V. and Herbert, J. (1990) The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggrressive and investigative behaviour in rats. Regul. Peptides 28, 199-214.
20. Emoto, H., Koga, C., Ishii, H., Yokoo, H., Yoshida, M. and Tanaka, M. (1993) The effect of CRF antagonist on immobilization stress-induced increases in noradrenaline release in rat brain regions. Yakabutsu Seishin Kodo 13, 81-87.
21. Farkilla, M., Ivanainen, M., Roine, R., Bergstrom, L., Laaksonen, R., Niemi, M. L. and Cantell, K. (1984) Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol. Scand. 69, 42-46.
22. Fatranska, M., Budai, D., Gulya, K. and Kvetnansky, R. (1989) Changes in acetylcholine content, release and muscarinic receptors in rat hippocampus under cold stress. Life Sci. 45, 143-149.
23. Garthwaite, J. (1993) Nitric oxide signalling in the nervous system. Sem. Neurosci. 5, 171-180.
24. Garthwaite, J., Charles, S. L. and Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in brain. Nature 336, 385-388.
25. Gisslinger, H., Svoboda, T., Clodi, M., Gilli, B., Ludwig, H., Havelec, L. and Luger, A. (1993) Interferon-α stimulates the hypothalamo-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinol. 57, 489-495.
26. Goldstein, G. and Borden, E. C. (1988) Interferons and neurologic disease: epilogue. In Interferon Treatment of Neurological Disorders, ed. R. A. Smith, pp. 321-331. Marcel Dekker, New York.
27. Gray, T. S., Carney, M. E. and Magnuson, D. J. (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433-446.
28. Gray, T. and Magnuson, D. J. (1992) Peptide immunoreactive neurons in the amygdala and the bed nucleus of stria terminalis project to the midbrain central grey in the rat.. Peptides 13, 451-460.
29. Gutterman, J. U. (1994) Cytokine therapeutics: lessons from interferon α. Proc. natn. Acad. Sci. USA. 91, 1198-1205.
30. Hary, L., Dupouy, J. P. and Chatelain, A. (1993) ACTH secretion from isolated hypophysial anterior lobes of male and female newborn rats: effects of corticotrophin-releasing factor, arginine vasopressin and oxytocin alone or in combination. J. Endocrinol. 137, 123-132.
31. Hillhouse, E. and Reichlin, S. (1990) Acetylcholine stimulates the secretion of corticotrophin-releasing factor from primary dissociated cell cultures of the rat telencephalon and diencephalon. Brain Res. 506, 9-13.
32. Honkaniemi, J., Pelto-Huikko, M., Rechard, L., Isola, J., Lammi, A., Fuxe, K., Gustafsson, J. A., Wikstrom, A. C. and Hokfelt, T. (1992) Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 55, 451-459.
33. Hu, S. B., Tannahill, L. A. and Lightman, S. L. (1992a) Interieukin-1 beta induces corticotrophin-releasing factor-41 release from cultured hypothalamic cells through protein kinase C and cAMP-dependent protein kinase pathways. J. Neuroimmunol. 40, 49-55.
34. Hu, S. B., Tannahill, L. A. and Lightman, S. L. (1992b) Mechanisms of norepinephrine mediated corticotrophin-releasing factor-41 release from cultured fetal hypothalamic cells. Neuroendocrinology 56, 712-718.
35. Hu, S. B., Lightman, S. L. and Tannahill, L. A. (1992c) 5-Hydroxytryptamine stimulates corticosteroid-sensitive CRF release from cultured foetal hypothalamic cells: role of protein kinases. Brain Res. 574, 266-270.
36. Hu, S. B., Tannahill, L. A., Biswas, S. and Lightman, S. L. (1992d) Release of corticotrophin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of intracellular second messengers and to corticosteroids. J. Neuroendocrinol. 132, 57-65.
37. Ishizuka, J., Beauchamp, R. D., Townsend, C. M. Jr. (1993) Novel action of transforming growth factor β 1 in functioning human pancreatic carcinoid cells. J. cell. Physiol. 156, 112-118.
38. Jones, M. T. and Hillhouse, E. W. (1977) Neurotransmitter regulation of corticotrophin-releasing factor in vitro. Ann. N. Y. Acad. Sci. 297, 536-560.
39. 1. J. IFN Res. 13, 143151.
40. Kiefer, R., Supler, M. L., Toyka, K. V. and Streit, W. J. (1994) In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells. Neurosci. Lett. 166, 161-164.
41. Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H., Miczek, K. and Britton, K. T. (1993) The role of corticotrophin-releasing factor in behavioural response to stress. CIBA Found. Symp. 172, 277-289.
42. 1 null mutation in mice causes excessive inflammatory response and early death. Proc. natn. Acad. Sci. USA 90, 770-774.
43. Lohmann, S. M., Waiter, U., Miller, P. E., Greengard, P. and De Camilli, P. (1981) Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc. natn. Acad. Sci. USA. 78, 653-657.
44. Lyson, K. and McCann, S. M. (1994) Alpha-melanocyte-stimulating hormone inhibits corticotrophin-releasing factor release by blocking protein kinase C. Neuroimmunomodulation 1, 153-158.
45. Makino, S., Gold, P. W. and Schulkin, J. (1994) Corticosterone effects on corticotrophin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640, 105-112.
46. Marczin, N., Ryan, U. S., Catravas, J. D. (1992) Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharmacol. exp. Ther. 263, 170-179.
47. 2 in serum and cerebrospinal fluid. Cancer Treat. Repts 68, 1057-1058.
48. Masek, K., Petrovicky, P. and Seifert, J. (1992) An introduction to the possible role of central nervous system structures in neuroendocrine-immune interaction. Int. J. Immunopharmacol. 14, 317-322.
49. Matheson, M. K., Branch, B. J. and Taylor, A. N. (1971) Effects of amygdaloid stimulation on pituitary-adrenal activity in conscious cats. Brain Res. 32, 151-167.
50. Mayer, B., Brunner, F. and Schmidt, K. (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45, 367-374.
51. Menzies, R. A., Phelps, C. P., Chen, L. T., Hall, N. R. S., Oliver, J., Poole, L., Horvath, E. and Wiranowska, M. (1994) Neuroimmunomodulatory effects of interferon. In Abstract Society for Neuroscience 1994, 392.3, Vol. 2, p. 954. ASN, Miami Beach, Florida.
52. Merimsky, O., Reider-Groswasser, I., Inbar, M. and Chaitnik, S. (1990) Interferon-related mental deterioration and behaviorial changes in patients with renal cell carcinoma. Eur. J. Cancer 26, 596-600.
53. Milton, N. G., Self, C. H. and Hillhouse, E. W. (1993) Effects of pyrogenic immunomodulators on the release of corticotrophin-releasing factor-41 and prostaglandin E2 from the intact rat hypothalamus in vitro. Br. J. Pharmacol. 109, 88-93.
54. Moga, M. M. and Gray, T. S. (1985) Evidence for corticotrophin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J. comp. Neurol. 241, 275-284.
55. Muller H., Hammes, E., Hiemke, C. and Hess, G. (1991) Interferon-α-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinoloay 54, 499-503.
56. Nakanishi, S., Maeda, N. and Mikoshiba, K. (1991) Immunohistochemical localization of an inositol 1,4,5-triphosphate receptor, P400 in neural tissue: studies in developing and adult mouse brain. J. Neurosci. 11, 2075-2086.
57. Nolten, W. E., Goldstein, D., Lindstrom, M., McKenna, M. V., Carlson, I. H., Trump, D. L., Schiller, J., Borden, E. C. and Ehrlich, E. N. (1993) Effect of cytokines on the pituitary adrenal axis in cancer patients. J. IFN Res. 13, 349-357.
58. Oki, Y., Nicholson, W. E., Orth, D. N. (1990) Role of protein kinase-C in the adrenocorticotrophin secretory response to arginine vasopressin (AVP) and the synergistic response to AVP and corticotrophin-releasing factor by perifused rat anterior pituitary cells. Endocrinology 127, 350-357.
59. Paxinos, P. and Watson, C. (1986) In The Rat Brain in Stereotaxic Coordinates. Academic Press, Perth, Australia.
60. Pfeffer, L. M. and Strulovici, B. (1992) Transmembrane secondary messengers for IFN α/β in Interferon: Principles and Medical Applications, pp. 151-160. The University of Texas Medical Branch at Galveston, Department of Microbiology, Galveston, Texas.
61. Premecz, G., Markovits, A. and Foldes, I. (1993) Signal transducing mechanisms in interferon action. Acta Microbiol. Hungary 40, 131-140.
62. 3H] noradrenaline from SH-SY5Y cells. J. Neurochem. 64, 1175-1182.
63. Raber, J. and Bloom, F. E. (1996) AVP release by acetylcholine and norepinephrine; region- and cytokine-specific regulation. Neuroscience 71, 747-759.
64. Raber, J., Koob, G. F. and Bloom, F. E. (1995) Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) from the amygdala and involves a nitric-oxide mediated signaling: comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272, 815-824.
65. Raber, J., Merlo Pich, E., Koob, G. F. and Bloom, F. E. (1994) IL-1β potentiates the acetylcholine induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Neuroendocrinol. 59, 208-217.
66. Redgate, E. S. and Fahringer, E. E. (1973) A comparison of the pituitary-adrenal activity elicited by electrical stimulation of preopitic, amygdaloid and hypothalamic sites in the rat brain. Neuroendocrinology 12, 334-343.
67. Rinner, I., Feisner, P., Falus, A., Skreiner, E., Kukulansky, T., Globerson, A., Hirokawa, K. and Schauenstein, K. (1995) Cholinergic signals to and from the immune system. Immunol. Lett. 44, 217-220.
68. Roberts, A. B. and Sporn, M. B. (1990) The transforming growth factors-β. In Handbook of Experimental Pharmacology, Peptide Growth Factors and their Receptors, eds M.B. Sporn and A. B. Roberts, Vol. 95, pp. 419-472. Springer, Heidelberg.
69. Rohatiner, A. Z. S., Prior, P. F., Burton, A. C. Smith, A. T., Balkwill, F. R. and Lister, T. A. (1983) Central nervous system toxicity of interferon. Br. J. Cancer. 47, 419-422.
70. 2. J. Neuroimmunol. 12, 311-316.
71. Sakanaka, M., Shibasaki, T. and Lederis, K. (1986) Distribution and efferent projections of corticotrophin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382, 213-238.
72. Sane, D. C., Bielawska, A., Greenberg, C. S. and Hannun, Y. A. (1989) Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. Biochem. biophys. Res. Comm. 165, 708-714.
73. 2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals. Antimicrob. Agents Chemother. 23, 589-592.
74. Shiozawa, S., Kuroki, Y., Kim, M., Hirohata, S. and Ogino, T. (1992) Interferon-α in lupus psychosis. Arthr. Rheumat. 35, 417-422.
75. Singh, V. B., Onaivi, E. S., Phan, T. H. and Boadlibiber, M. C. (1990) The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala. Brain Res. 530, 49-53.
76. Skowsky, W., Rosembloom, A. A. and Fisher, D. A. (1974) Radioimmunoassay of arginine vasopressin in serum: development and application. J. clin. Endocrinol. Metab. 38, 278-287.
77. Suda, T., Yajima, F., Tomori, N., Sumitomo, T., Nakagami, Y., Ushiyama, T., Demura, H. and Shizume, K. (1987) Stimulatory effect of acetylcholine on immunoreactive corticotrophin-releasing factor release from the hypothalamus in vitro. Life Sci. 40, 673-677.
78. Swanson, L. W. and Simmons, D. M. (1989) Organization of ovine corticotrophin-releasing factor immunoreactive cells and fibres in the rat brain: an immunohistochemical study. Nenroendocrinology 36, 165-186.
79. Tada, T., Yabu, K. and Kobayashi, S. (1993) Detection of active form of transforming growth factor-β in cerebrospinal fluid of patients with glioma. Jap. J. Cancer Res. 84, 544-548.
80. Take, S., Mori, T., Katafuchi, T. and Hori, T. (1993) Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am. J. Physiol. 265, R453-459.
81. Tsagarakis, S., Holly, J. M. P., Rees, L. H., Besser, G. M. and Grossman, A. (1988) Acetylcholine and norepinephrine stimulate the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology 123, 1962-1969.
82. Unsicker, K., Flanders, K. C., Cissel, D. S., Lafyatis, R. and Sporn, M. B. (1991) Transforming growth factor β isoforms in the adult rat central and peripheral nervous system. Neuroscience 44, 613-625.
83. Wahl, S. M., Allen, J. B., McCartney-Francis, N., Morganti-Kossmann, M. C., Kossman, T., Ellingworth, L. and Mai, U. E. (1991) Macrophage and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173, 981-991.
84. Weitzman, R., Glatz, T. H. and Fisher, D. A. (1978) The effect of hemorrhage and hypertonic saline upon plasma oxytocin and arginine vasopressin in conscious dogs. Endocrinology 103, 1411-1414.
85. Wesselingh, S. L., Gough, N. M., Finlay-Jones, J. J. and McDonald, P. J. (1990) Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res. 9, 177-1850.